Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: J Invest Dermatol. 2018 Jul 14;138(11):2432–2442. doi: 10.1016/j.jid.2018.04.029

Figure 2. Fibronectin promotes BCC adhesion and migration.

Figure 2.

(a)Crystal violet staining of adhesion assays performed with UW_BCC_T2 and ASZ_001 on BSA, collagen I or fibronectin. Scale bars indicate 1mm.

(b) Quantification of adhesion assays shown in (a).

(c) Crystal violet staining of long-term clonogenic assays performed with UW_BCC_T2 and ASZ_001 on uncoated or fibronectin-coated plates.

(d) Timecourse and crystal violet staining of migration assays performed with UW_BCC_T2 on uncoated or fibronectin-coated plates.

(e) Timecourse and crystal violet staining of migration assays performed with ASZ_001 on uncoated or fibronectin-coated plates.

(f) Tumor cell velocity measured from migration assays performed in (d) and (e).

Scale bars indicate 100μm (unless specified). Columns and error bars represent the mean ± SD for n ≥ 3 per group. *p < 0.05, **p < 0.01 and ***p < 0.001.